Search Result for : Us Market

The Dollar Business Bureau A leading Indian pharmaceuticals company Aurobindo Pharma has said that it would widen its product portfolio in the American market while planning to enter new markets in the Europe, a part of the company’s growth strategy in the coming 3-4 years. In the US market, Aurobindo Pharma plans to widen its portfolio through faster growth in OTC, injectable and higher complexity products, the company said in a presentation to investors. However, in European market, the company plans to enhance its presence in new geographies like Czech Republic and Poland, in addition to strengthening its position in the existing markets of Germany, France, Spain, Netherlands and the UK. Aurobindo Pharma is the 6th largest generic company by volume in the US, ...

The Dollar Business Bureau US and China failed to agree on major new steps to reduce US's trade deficit with China, leading to doubts over the economic and security relationship between the two countries. The annual economic session in Washington dubbed by the Trump administration as US-China Comprehensive Economic Dialogue (CED) ended with both the sides refusing to hold news briefs or joint statements with no news announcements on US market access to China. Though both the sides had open and frank talks, they failed to come to a consensus on major bilateral and economic issues that were important for the US. According to Reuters, US had asked for-  major access to China's financial services markets, reduction in China's steel capacity, reduction in auto tarriffs, ...

The Dollar Business Bureau The exports and imports of China increased in the month of April, as foreign and domestic demand weakened and there was a decline in commodity prices. In April, China's exports surged 8% compared to the previous year, missing analysts' predictions, whereas imports expanded 11.9%, an official data revealed on Monday. This has left $38.05 billion of trade surplus for the country in the given month, China’s General Administration of Customs revealed. In March, the country’s exports grew 16.4% and imports rose 20.3%. China's trade surplus in the month of March stood at $23.93 billion. Last week, the Chinese Ministry of Commerce, in its quarterly report, said that the country’s exports and imports are likely to be stabilised and improved in near future. Foreign ...

The Dollar Business Bureau Probably never in the political history of the United States has a President caused such ripples in the economic environment even before being sworn in.  Walmart and General Motors, in tandem with the new stance adopted by US Presidency on aggressive job creation in the manufacturing sector, have both announced robust investments and job creation in the USA in 2017. GM proposed an additional $1 billion investment over and above the already announced figure of $2.6 billion in 2016. The dominant automobile player plans to create 7000 new jobs in the US over the next two to three years. This net number includes IT jobs it's going to bring back home from overseas, 450 jobs in the axle production and 1,500 jobs that ...

Source: PTI British IT and software firm RSK Business Solutions has merged with its Indian partner BSL Information Technology to jointly deliver consultancy services in different parts of the world. England-headquartered RSK Business Solutions Limited (RSK BSL) merged with its Gurgaon-based Indian partner BSL Information Technology Private Limited (BSLi) to create UK-registered RSK Business Solutions Holdings Limited. The merger will enable both entities to jointly expand services to new regions and markets, the firms said on Monday. "The merger will enable us to provide a wider range of services to new and existing clients while maintaining the high levels of customer service and the high quality of output to which our clients have become accustomed," Managing Director of the ...

The Dollar Business Bureau Rating agency ICRA on Thursday said that the Indian pharmaceutical industry will witness moderation in growth due to slow down of business in the US with a decline in the volume of large size drugs going off patent, increasing competition and adoption of generics reaching a saturation level. Over the last 10 years, the Indian pharmaceutical companies have witnessed a strong growth driven largely by the US market. "However, the growth from the US market has been down to 15 percent in financial year 2015-16 and looking forward the momentum for growth is possibly to face more pressure," ICRA (Investment Information and Credit Rating Agency of India) said in a statement. The Indian drug companies will have an impact on ...

The growth estimate has been revised down from 10%-12% to 5% for the current fiscal due to increased regulatory actions faced by Indian drug makers The Dollar Business Bureau India Rating and Research has revised the pharma sectors outlook for FY17 to stable from positive and said it expects muted export revenue growth and stable domestic revenue growth during the year   Indian pharmaceuticals exports, embattled with increased global regulations and depreciation of emerging market currencies, are expected to grow at a modest pace of 5% during the financial year 2016-17, a report has said. The domestic pharmaceutical market is likely to sustain the recently gained momentum of 13%-15% growth rate. However, the market will remain exposed to any expansion of the price control ...

Source: PTI    Aiming to diversify globally, India-based leather goods manufacturer Hidesign is bullish on growing its presence in the US market and is seeking to capture the niche segment with its range of men's and women's range of bags. Pondicherry-based Hidesign launched its US operations in December 2014, making an initial investment of between a quarter and half million dollars. The company plans to make more investments as it undertakes expansion of the brand in the US market. “The US market is gigantic and we are looking for a niche representation in this market, that itself will be very significant in terms of numbers and value. It is a good opportunity to diversify and build the brand outside India,” Hidesign ...